NEW YORK, May 7 (GenomeWeb News) - Bio-Rad yesterday reported increased revenues but a drop in income for the first quarter of 2004.
Bio-Rad's revenues increased 8.4 percent year-over-year to $266.6 million in the quarter, from $246 million in the comparable quarter of 2003.
...and receive Daily News bulletins.
Already have an account?Login Now.
Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.
The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.
US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.
In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.